BellRinger, Georgetown Lombardi Comprehensive Cancer Center’s Inaugural Bike Ride to End Cancer, Commences Saturday
Mary Ellen Garrett
WASHINGTON (October 20, 2022) — BellRinger, a bike ride and community movement, will commence its inaugural 25-, 50, and 100-mile fundraising ride this Saturday, October 22, with an opening ceremony to kick off festivities on Friday, October 21. BellRinger has registered more than 800 riders with the goal to raise over $1.4 million. Local cancer survivors, cancer researchers, avid cyclists, and new and casual riders will all unite in the mission of ending cancer.
“Our inaugural ride to end cancer is finally here,” said Louis Weiner, MD, director of Georgetown Lombardi Comprehensive Cancer Center. “We’re building a community of survivors and supporters with BellRinger, while at the same time introducing a critical new way to fund breakthroughs in cancer research. I want to thank each and every person who has put in the energy to ride and fundraise. The entire BellRinger community is making an impact that will save lives.”
BellRinger riders have trained for a 25-, 50-, or 100-mile bike ride to fund groundbreaking cancer research at Georgetown Lombardi.
“The BellRinger community is riding their bikes together for the first time in our fight to end cancer,” said Chris Timko, BellRinger executive director. “All the positive energy behind this ambitious new community movement is going to create a meaningful impact on cancer research at Georgetown Lombardi for years to come.”
BellRinger, Georgetown Lombardi Comprehensive Cancer Center’s year-round community effort to end cancer, is a bold project to unite riders from D.C., Maryland and Virginia around a common cause. BellRinger’s inaugural ride will stretch from Washington, D.C., to Urbana, Maryland.
Georgetown Lombardi is the only National Cancer Institute (NCI) designated comprehensive cancer center in the D.C. area and has been a leader in cancer research for over 50 years — from breakthroughs in breast cancer treatment to contributing to the creation of the HPV vaccine and enabling “bench to bedside” research and clinical trials with their clinical partner MedStar Health.
BellRinger is Georgetown Lombardi Comprehensive Cancer Center’s year-round community effort to end cancer. BellRinger riders train to fundraise for cancer research in advance of BellRinger weekend, a 25-, 50-, and 100-mile bike ride starting in Georgetown on October 22, 2022. For more information, visit https://bellringer.org/ and follow BellRinger on Instagram, Facebook, and Twitter.